Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_assertion description "[As a main observation, carriers of the A allele of the CENPF SNP rs438034 had a worse BC-specific survival compared to the wild type genotype GG carriers (hazard ratio (HR) 2.65, 95% confidence interval (CI) 1.19-5.90), although they were less likely to have regional lymph node metastases (odds ratio (OR) 0.71, 95% CI 0.51-1.01) and tumours of stage II-IV (OR 0.73, 95% CI 0.54-0.99).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_assertion evidence source_evidence_literature NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_assertion SIO_000772 19008095 NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_assertion wasDerivedFrom befree-20150227 NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_assertion wasGeneratedBy ECO_0000203 NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP310460.RADth5Dbb7582MmEZs8QVvRtsbzwYQrJM-Z3ZiNFHMx0s130_provenance.